Work

Can Eptifibatide Rewrite the NSTEMI Story? (Eptifibatide vs. Standard Care for NSTEMI: A 5‐Year Analysis of Major Adverse Cardiovascular Events)

Year: 2025

Type: article

Study design: Observational Study

Source: Catheterization and Cardiovascular Interventions

DOI: 10.1002/ccd.70242

Authors: Parvin Kalhor, Pargol Nowrouzi, Parichehr Ghahari, Mehdi Mehrani

Institutions: Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415419097

FWCI: 0.649

Cites: 2

Cited by: 1

Related to: